These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29159526)

  • 1. Cardiovascular disease in kidney transplant recipients: Japan Academic Consortium of Kidney Transplantation (JACK) cohort study.
    Okumi M; Kakuta Y; Unagami K; Maenosono R; Miyake K; Iizuka J; Takagi T; Ishida H; Tanabe K;
    Clin Exp Nephrol; 2018 Jun; 22(3):702-709. PubMed ID: 29159526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.
    Merhi B; Shireman T; Carpenter MA; Kusek JW; Jacques P; Pfeffer M; Rao M; Foster MC; Kim SJ; Pesavento TE; Smith SR; Kew CE; House AA; Gohh R; Weiner DE; Levey AS; Ix JH; Bostom A
    Am J Kidney Dis; 2017 Sep; 70(3):377-385. PubMed ID: 28579423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Prediction of Cardiovascular Disease in Kidney Transplant Recipients.
    Bilancio G; Celano M; Cozza V; Zingone F; Palladino G; Cirillo M
    Transplant Proc; 2017 Nov; 49(9):2092-2098. PubMed ID: 29149967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients.
    Kang AW; Bostom AG; Kim H; Eaton CB; Gohh R; Kusek JW; Pfeffer MA; Risica PM; Garber CE
    Nephrol Dial Transplant; 2020 Aug; 35(8):1436-1443. PubMed ID: 32437569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
    Dad T; Tighiouart H; Joseph A; Bostom A; Carpenter M; Hunsicker L; Kusek JW; Pfeffer M; Levey AS; Weiner DE
    Am J Kidney Dis; 2016 Aug; 68(2):277-286. PubMed ID: 26947217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol.
    Pita-Fernández S; Pértega-Díaz S; Valdés-Cañedo F; Seijo-Bestilleiro R; Seoane-Pillado T; Fernández-Rivera C; Alonso-Hernández A; Lorenzo-Aguiar D; López-Calvino B; López-Muñiz A
    BMC Cardiovasc Disord; 2011 Jan; 11():2. PubMed ID: 21639867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk and prognosis of bacteremia and fungemia among first-time kidney transplant recipients: a population-based cohort study.
    Skov Dalgaard L; Nørgaard M; Povlsen JV; Morrissey O; Jespersen B; Jensen-Fangel S; Østergaard LJ; Schønheyder HC; Søgaard OS
    Infect Dis (Lond); 2017 Apr; 49(4):286-295. PubMed ID: 27822975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and magnitude of post-transplant cardiovascular disease after pediatric kidney transplantation: Risk factor analysis of 1058 pediatric kidney transplants at the university of Minnesota.
    Serrano OK; Bangdiwala AS; Vock DM; Chinnakotla S; Dunn TB; Finger EB; Kandaswamy R; Pruett TL; Najarian JS; Matas AJ; Chavers B
    Pediatr Transplant; 2018 Nov; 22(7):e13283. PubMed ID: 30151948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014).
    Awan AA; Niu J; Pan JS; Erickson KF; Mandayam S; Winkelmayer WC; Navaneethan SD; Ramanathan V
    Am J Nephrol; 2018; 48(6):472-481. PubMed ID: 30472701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index and metabolic syndrome impact differently on major clinical events in renal transplant patients.
    De Giorgi A; Storari A; Forcellini S; Manfredini F; Lamberti N; Todeschini P; La Manna G; Manfredini R; Fabbian F
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4654-4660. PubMed ID: 29131248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher mortality risk among kidney transplant recipients than among estimated glomerular filtration rate-matched patients with CKD-preliminary results.
    Cheddani L; Liabeuf S; Essig M; Snanoudj R; Jacquelinet C; Kerleau C; Metzger M; Balkau B; Drüeke TB; Hourmant M; Massy ZA;
    Nephrol Dial Transplant; 2021 Jan; 36(1):176-184. PubMed ID: 32162656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Angiopoietins in Cardiovascular Outcomes of Kidney Transplant Recipients: An Ancillary Study from the FAVORIT.
    Gendy N; Brown L; Staunton MK; Garg K; Hernandez Garcilazo N; Qian L; Yamamoto Y; Ugwuowo U; Obeid W; Al-Qusairi L; Bostom A; Mansour SG
    Am J Nephrol; 2024; 55(5):597-606. PubMed ID: 38735283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Acidosis and Long-Term Clinical Outcomes in Kidney Transplant Recipients.
    Park S; Kang E; Park S; Kim YC; Han SS; Ha J; Kim DK; Kim S; Park SK; Han DJ; Lim CS; Kim YS; Lee JP; Kim YH
    J Am Soc Nephrol; 2017 Jun; 28(6):1886-1897. PubMed ID: 28031407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remnant cholesterol is prospectively associated with cardiovascular disease events and all-cause mortality in kidney transplant recipients: the FAVORIT study.
    Horace RW; Roberts M; Shireman TI; Merhi B; Jacques P; Bostom AG; Liu S; Eaton CB
    Nephrol Dial Transplant; 2022 Jan; 37(2):382-389. PubMed ID: 33760035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of primary diabetic nephropathy on arteriolar hyalinosis lesions in patients following kidney transplantation.
    Yamakawa T; Kobayashi A; Yamamoto I; Kawaguchi T; Imasawa T; Aoyama H; Akutsu N; Maruyama M; Saigo K; Yokoo T; Kitamura H
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():70-75. PubMed ID: 29968417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Risk Evaluated With the Use of Heartscore in Kidney Transplant Recipients-Three Years of Follow-up.
    Gozdowska J; Jędrych E; Chabior A; Kieszek R; Kwiatkowski A; Chmura A; Durlik M
    Transplant Proc; 2016 Jun; 48(5):1570-5. PubMed ID: 27496449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease in early kidney transplantation: comparison between living and deceased donor recipients.
    Yazbek DC; de Carvalho AB; Barros CS; Marcassi AP; Pestana JO; Fachini FC; Cassiolato JL; Canziani ME
    Transplant Proc; 2012 Dec; 44(10):3001-6. PubMed ID: 23195014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo major cardiovascular events in kidney transplant recipients: a comparative matched cohort study.
    Kim JE; Park J; Park S; Yu MY; Baek SH; Park SH; Han K; Kim YC; Kim DK; Oh KH; Joo KW; Kim YS; Lee H
    Nephrol Dial Transplant; 2023 Feb; 38(2):499-506. PubMed ID: 35396847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
    Bostom A; Pasch A; Madsen T; Roberts MB; Franceschini N; Steubl D; Garimella PS; Ix JH; Tuttle KR; Ivanova A; Shireman T; Gohh R; Merhi B; Jarolim P; Kusek JW; Pfeffer MA; Liu S; Eaton CB
    Am J Nephrol; 2018; 48(1):21-31. PubMed ID: 29996127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and management of hypertension in paediatric and young adult kidney transplant recipients in The Netherlands.
    Dobrowolski LC; van Huis M; van der Lee JH; Peters Sengers H; Liliën MR; Cransberg K; Cornelissen M; Bouts AH; de Fijter JW; Berger SP; van Zuilen A; Nurmohamed SA; Betjes MH; Hilbrands L; Hoitsma AJ; Bemelman FJ; Krediet CTP; Groothoff JW
    Nephrol Dial Transplant; 2016 Nov; 31(11):1947-1956. PubMed ID: 27288460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.